Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Arqule Inc (ARQL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 527,777
  • Shares Outstanding, K 108,820
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,200 K
  • 36-Month Beta 1.03
  • Price/Sales 22.85
  • Price/Cash Flow N/A
  • Price/Book 20.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.06
  • Number of Estimates 4
  • High Estimate -0.04
  • Low Estimate -0.10
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.78 +7.22%
on 09/19/18
6.73 -23.85%
on 09/04/18
-0.55 (-9.77%)
since 08/20/18
3-Month
4.45 +15.17%
on 06/21/18
7.21 -28.92%
on 07/09/18
+0.39 (+8.12%)
since 06/20/18
52-Week
0.97 +428.35%
on 10/31/17
7.21 -28.92%
on 07/09/18
+3.97 (+345.65%)
since 09/20/17

Most Recent Stories

More News
Miransertib (ARQ 092) Granted Fast Track Designation for the Treatment of PIK3CA-Related Overgrowth Spectrum (PROS)

ArQule, Inc. (Nasdaq: ARQL) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to miransertib (ARQ 092) for the treatment of PIK3CA-Related...

ARQL : 5.11 (+5.36%)
Implied Volatility Surging for ArQule (ARQL) Stock Options

Investors need to pay close attention to ArQule (ARQL) stock based on the movements in the options market lately.

ARQL : 5.11 (+5.36%)
ArQule to Participate in Citi's 13th Annual Biotech Conference on September 6, 2018

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, CEO, Peter Lawrence, President and COO, Brian Schwartz, CMO and Head of R&D and Marc Schegerin, Senior Vice President and Head...

ARQL : 5.11 (+5.36%)
ArQule to Participate in the Annual B. Riley FBR Healthcare Conference on September 4, 2018

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, CEO, and Dr. Brian Schwartz, CMO and Head of Research and Development, will participate in investor meetings and scientific panel...

ARQL : 5.11 (+5.36%)
ArQule to Present at the 20th Annual Global Investment Conference on September 5, 2018

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Strategy, Communication and Finance, will present at the...

ARQL : 5.11 (+5.36%)
Analysis: Positioning to Benefit within PagSeguro Digital, ChannelAdvisor, Transocean, Arcos Dorados, Precision Drilling, and ArQule -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PagSeguro Digital Ltd. (NYSE:PAGS),...

RIG : 12.66 (+2.43%)
ARQL : 5.11 (+5.36%)
ARCO : 6.75 (+2.27%)
PAGS : 28.76 (+1.20%)
ECOM : 11.05 (+0.45%)
PDS : 3.73 (-1.58%)
Medical-Drugs Stock Outlook: No Respite from Near-Term Pain

Medical-Drugs Stock Outlook: No Respite from Near-Term Pain

RDHL : 7.90 (-1.25%)
ARQL : 5.11 (+5.36%)
AERI : 57.40 (+2.14%)
GLMD : 12.91 (+0.94%)
ArQule (ARQL) Beats Q2 Earnings and Revenue Estimates

ArQule (ARQL) delivered earnings and revenue surprises of 150.00% and 78.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ARQL : 5.11 (+5.36%)
ArQule Reports Second Quarter 2018 Financial Results

ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the second quarter of 2018.

ARQL : 5.11 (+5.36%)
Is Exelixis (EXEL) Poised for a Beat Again in Q2?

Exelixis (EXEL) is likely to beat earnings again in the second quarter, driven by favourable metrics. Investors will focus on the company's uptake in the first-line RCC setting, along with other updates....

ARQL : 5.11 (+5.36%)
EXEL : 16.62 (+1.09%)
RHHBY : 30.5000 (-0.16%)
BMY : 61.56 (+1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators are in flux.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ARQL with:

Business Summary

ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage...

See More

Key Turning Points

2nd Resistance Point 5.40
1st Resistance Point 5.13
Last Price 5.11
1st Support Level 4.68
2nd Support Level 4.50

See More

52-Week High 7.21
Last Price 5.11
Fibonacci 61.8% 4.83
Fibonacci 50% 4.09
Fibonacci 38.2% 3.35
52-Week Low 0.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar